Sign inJoin waitlistJoin the waitlist

RL

Rachel Lerner

Core Investigator, Cancer Research Center and Investigator, Metro-Minnesota Community Oncology Research Consortium · University of Minnesota

Credentials: · · · · · ·

History

University of Minnesota
Present

Hematology and Medical Oncology
2001–2004
Internal Medicine
1998–2001
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1994–1998

Research

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN…
The Lancet Oncology · 2016 · 116 citations
The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial…
Biology of Blood and Marrow Transplantation · 2007 · First of 5 authors · 44 citations
Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)
Breast Cancer Research and Treatment · 2016 · Last of 7 authors · 37 citations

LB
Linda Burns
2 papers
Ahmed Khalid
1 paper
Alyssa Throckmorton
1 paper
AH
Amanda Hathaway
1 paper
Andrew Pippas
1 paper
Ashlesha Patel
1 paper
BK
Brad Kahl
1 paper
Brian Till
1 paper
Carla Casulo
1 paper
Curtis Hanson
1 paper
Daniel Weisdorf
1 paper
David Carbone
1 paper